Impact of Exposure to Malaria and Nutritional Status on Responses to the Experimental Malaria Vaccine ChAd63 MVA ME-TRAP in 5-17 Month-old Children in Burkina Faso

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2022 Dec 19

PMID 36532031

Authors

Richard Morter

Alfred B Tiono

Issa Nebie

Oliver Hague

Alphonse Ouedraogo

Amidou Diarra

Nicola K Viebig

Adrian V S Hill

Katie J Ewer

Sodiomon B Sirima

Affiliations

Soon will be listed here.

Abstract

Trial Registration: Pactr.org, identifier PACTR201208000404131; ClinicalTrials.gov, identifier NCT01635647.

Citing Articles

Evaluating artesunate monotherapy and dihydroartemisinin-piperaquine as potential antimalarial options for prevaccination radical cures during future malaria vaccine field efficacy trials.

Ouedraogo A, Ouattara D, Ouattara S, Diarra A, Badoum E, Hema A Malar J. 2024; 23(1):377.

PMID: 39695728 PMC: 11656655. DOI: 10.1186/s12936-024-05198-1.

Role of homologous recombination/recombineering on human adenovirus genome engineering: Not the only but the most competent solution.

Dawson L, Alshawabkeh M, Schroer K, Arakrak F, Ehrhardt A, Zhang W Eng Microbiol. 2024; 4(1):100140.

PMID: 39628785 PMC: 11611009. DOI: 10.1016/j.engmic.2024.100140.

The impact of Plasmodium-driven immunoregulatory networks on immunity to malaria.

Boyle M, Engwerda C, Jagannathan P Nat Rev Immunol. 2024; 24(9):637-653.

PMID: 38862638 PMC: 11688169. DOI: 10.1038/s41577-024-01041-5.

Previous Malaria Exposures and Immune Dysregulation: Developing Strategies To Improve Malaria Vaccine Efficacy in Young Children.

Dobbs K, Atieli H, Valim C, Beeson J Am J Trop Med Hyg. 2024; 110(4):627-630.

PMID: 38442424 PMC: 10993830. DOI: 10.4269/ajtmh.23-0696.

Immunological factors linked to geographical variation in vaccine responses.

van Dorst M, Pyuza J, Nkurunungi G, Kullaya V, Smits H, Hogendoorn P Nat Rev Immunol. 2023; 24(4):250-263.

PMID: 37770632 DOI: 10.1038/s41577-023-00941-2.

References

Mensah V, Gueye A, Ndiaye M, Edwards N, Wright D, Anagnostou N . Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal. PLoS One. 2016; 11(12):e0167951. PMC: 5158312. DOI: 10.1371/journal.pone.0167951. View

Gaayeb L, Pincon C, Cames C, Sarr J, Seck M, Schacht A . Immune response to Bordetella pertussis is associated with season and undernutrition in Senegalese children. Vaccine. 2014; 32(27):3431-7. DOI: 10.1016/j.vaccine.2014.03.086. View

Agnandji S, Lell B, Fernandes J, Abossolo B, Methogo B, Lumeka Kabwende A . A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med. 2012; 367(24):2284-95. PMC: 10915853. DOI: 10.1056/NEJMoa1208394. View

Murphy S, Deye G, Sim B, Galbiati S, Kennedy J, Cohen K . PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection. PLoS Pathog. 2021; 17(5):e1009594. PMC: 8191919. DOI: 10.1371/journal.ppat.1009594. View

Imwong M, Hanchana S, Malleret B, Renia L, Day N, Dondorp A . High-throughput ultrasensitive molecular techniques for quantifying low-density malaria parasitemias. J Clin Microbiol. 2014; 52(9):3303-9. PMC: 4313154. DOI: 10.1128/JCM.01057-14. View

Frimpong A, Amponsah J, Adjokatseh A, Agyemang D, Bentum-Ennin L, Ofori E . Asymptomatic Malaria Infection Is Maintained by a Balanced Pro- and Anti-inflammatory Response. Front Microbiol. 2020; 11:559255. PMC: 7705202. DOI: 10.3389/fmicb.2020.559255. View

Cunnington A, Riley E . Suppression of vaccine responses by malaria: insignificant or overlooked?. Expert Rev Vaccines. 2010; 9(4):409-29. DOI: 10.1586/erv.10.16. View

Scholzen A, Cooke B, Plebanski M . Plasmodium falciparum induces Foxp3hi CD4 T cells independent of surface PfEMP1 expression via small soluble parasite components. Front Microbiol. 2014; 5:200. PMC: 4013457. DOI: 10.3389/fmicb.2014.00200. View

Agnandji S, Lell B, Soulanoudjingar S, Fernandes J, Abossolo B, Conzelmann C . First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med. 2011; 365(20):1863-75. DOI: 10.1056/NEJMoa1102287. View

10.

Healer J, Cowman A, Kaslow D, Birkett A . Vaccines to Accelerate Malaria Elimination and Eventual Eradication. Cold Spring Harb Perspect Med. 2017; 7(9). PMC: 5580511. DOI: 10.1101/cshperspect.a025627. View

11.

Bousema T, Drakeley C, Gesase S, Hashim R, Magesa S, Mosha F . Identification of hot spots of malaria transmission for targeted malaria control. J Infect Dis. 2010; 201(11):1764-74. DOI: 10.1086/652456. View

12.

. Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites. PLoS Med. 2014; 11(7):e1001685. PMC: 4114488. DOI: 10.1371/journal.pmed.1001685. View

13.

Lamsfus Calle C, Mordmuller B, Singh A . Immunosuppression in Malaria: Do Parasites Hijack the Host?. Pathogens. 2021; 10(10). PMC: 8536967. DOI: 10.3390/pathogens10101277. View

14.

Olotu A, Fegan G, Wambua J, Nyangweso G, Ogada E, Drakeley C . Estimating individual exposure to malaria using local prevalence of malaria infection in the field. PLoS One. 2012; 7(3):e32929. PMC: 3315550. DOI: 10.1371/journal.pone.0032929. View

15.

Ogwang C, Kimani D, Edwards N, Roberts R, Mwacharo J, Bowyer G . Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults. Sci Transl Med. 2015; 7(286):286re5. PMC: 4687051. DOI: 10.1126/scitranslmed.aaa2373. View

16.

Weiss G, Crompton P, Li S, Walsh L, Moir S, Traore B . Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area. J Immunol. 2009; 183(3):2176-82. PMC: 2713793. DOI: 10.4049/jimmunol.0901297. View

17.

Joanny F, Lohr S, Engleitner T, Lell B, Mordmuller B . Limit of blank and limit of detection of Plasmodium falciparum thick blood smear microscopy in a routine setting in Central Africa. Malar J. 2014; 13:234. PMC: 4069274. DOI: 10.1186/1475-2875-13-234. View

18.

Prendergast A . Malnutrition and vaccination in developing countries. Philos Trans R Soc Lond B Biol Sci. 2015; 370(1671). PMC: 4527386. DOI: 10.1098/rstb.2014.0141. View

19.

Hodgson S, Choudhary P, Elias S, Milne K, Rampling T, Biswas S . Combining viral vectored and protein-in-adjuvant vaccines against the blood-stage malaria antigen AMA1: report on a phase 1a clinical trial. Mol Ther. 2014; 22(12):2142-2154. PMC: 4250079. DOI: 10.1038/mt.2014.157. View

20.

Maizels R, McSorley H . Regulation of the host immune system by helminth parasites. J Allergy Clin Immunol. 2016; 138(3):666-675. PMC: 5010150. DOI: 10.1016/j.jaci.2016.07.007. View